Please login to the form below

Not currently logged in
Email:
Password:

Sanofi nominates Bonnie Bassler to board

She has over 20 years of experience
Bonnie Bassler

Sanofi has nominated Bonnie Bassler as an independent member of its board of directors.

Bassler serves as a member of the US National Science Board, as appointed by president Barack Obama, which oversees the National Science Foundation.

Her appointment comes shortly after Sanofi's board sacked CEO Christoper Viehbacher.

Commenting on her nomination, Bassler said: “It is a great honour for me to join Sanofi's board of directors. Sanofi is one of the leading international pharmaceutical companies in the world and I look forward to working closely with members on the board and the company to support Sanofi's mission to develop and introduce innovative therapies.”

Bassler has more than 20 years of experience in the sector and is a Howard Hughes Medical Institute investigator, professor in molecular biology and chair of the department of molecular biology at Princeton University, US.

She also serves on oversight, grant, fellowship and award panels for organisations including the National Academies of Sciences and US National Institutes of Health.

Serge Weinberg, chairman of the board and interim CEO at Sanofi, said: “Professor Bassler's scientific expertise in molecular biology and her great leadership skills makes her an outstanding addition to our board.

“We look forward to her contribution to Sanofi's strategy as we continue to innovate and introduce new medicines and vaccines that can help improve health outcomes.”

27th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics